Clinical trials
Phase 3 Post-Acute COVID-19 Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 4 |
| Recruiting | 4 |
| Terminated | 1 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Cardresearch | 1 |
| Douglas D. Fraser | 1 |
| Emory University | 1 |
| Erasmus Medical Center | 1 |
| Federal University of São Paulo | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Janneke van de Wijgert | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| Materia Medica Holding | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Post-Acute COVID-19 Syndrome | 21 |
| COVID-19 | 6 |
| Fatigue Syndrome, Chronic | 3 |
| Fatigue | 2 |
| Inflammation | 2 |
| Anosmia | 1 |
| Coronavirus Infections | 1 |
| Disease | 1 |
| Fibrosis | 1 |
| Lung Diseases | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.